Biologics Spine Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data byTim AllenMay 13, 2025
Neuro Spine Mainstay Medical Announces Positive Results from the Landmark ReActiv8® RESTORE Clinical Trial byTim AllenJanuary 16, 2025
Biologics Spine BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data byTim AllenNovember 13, 2024
Biologics Neuro Early data demonstrate motor function improvement for spinal cord stem cell treatment byJosh SandbergJanuary 26, 2017
Biologics Grafix® Manuscript Reporting Positive Outcomes of Multicenter Chronic Complex Wounds with Exposed Tendon and Bone Clinical Trial is Available Electronically in Peer-Reviewed Journal byJosh SandbergAugust 9, 2016
Hospitals Bone Therapeutics announces further positive efficacy in ALLOB® Phase I/IIA delayed-union fracture trial byJosh SandbergMay 18, 2016
Spine Blue Cross Blue Shield of Michigan Announces Positive Coverage Policy for iFuse Implant System® MIS SI Joint Fusion byJosh SandbergMarch 21, 2016
Financial SI-BONE, Inc. Announces Medicare Administrative Contractor CGS Administrators, LLC Establishes Positive Coverage for MIS SI Joint Fusion Effective February 1st, 2016 byJosh SandbergDecember 21, 2015
Recon CollPlant Reports Positive Interim Trial Results for Vergenix™STR, Indicated for the Treatment of Tendinopathy byJosh SandbergDecember 9, 2015
Spine ‘Floating’ plaque technique can provide additional spinal cord decompression byJosh SandbergNovember 24, 2015
